Can BPC-157 and TB-500 Help Scars Heal After a Tummy Tuck?

No study in people has tested BPC-157 or TB-500 on surgical incisions, so no one can promise they will make a tummy tuck or breast reduction scar heal faster. The case for trying them comes from animal research. In those studies, BPC-157 helped skin cuts and burns close faster, and thymosin beta-4, the protein TB-500 comes from, sped skin wound healing. If you want to add one to your recovery, do it with a clinical team that knows your surgery, your medications and your health history.

What does the research show for BPC-157 on skin wounds and incisions?

BPC-157 has been studied in animals on the same kinds of skin wounds surgery leaves. A review of BPC-157 and wound healing covers animal studies on cut wounds, wounds where skin was removed, deep burns, chemical burns and slow-healing diabetic ulcers. That makes this research closer to a fresh incision than the tendon and gym-injury studies most peptide pages talk about.

The burn results are the most striking. In rats with a chemical skin burn, BPC-157 put on the skin helped the wound close and the skin rebuild within 2 to 3 weeks. Burns like that can take several months to heal.

Researchers think BPC-157 helps in a few ways. It encourages new blood vessels to grow, boosts collagen, helps repair cells move into the wound, and keeps inflammation from running too long. Part of this works through nitric oxide, a molecule that widens blood vessels. In the animal and lab studies, that meant more blood supply and more collagen-building where the skin was trying to knit back together.

The human research is thin. A 2025 review found only three small pilot studies of BPC-157 in people. One tested knee injections for pain, one tested it for interstitial cystitis (a painful bladder condition), and one was an IV safety study. None of them looked at skin, incisions or scars.

Is TB-500 the same as thymosin beta-4 for wound healing?

No. TB-500 is a short fragment of thymosin beta-4, a protein your body makes on its own. The FDA lists it as "Thymosin beta-4, fragment (LKKTETQ), also known as TB-500."

Thymosin beta-4 is the one with the wound-healing record. A review of thymosin beta-4 says it can promote wound healing and reduce scar formation. It cites a 2012 paper titled "The Regenerative Peptide Thymosin β4 Accelerates the Rate of Dermal Healing in Preclinical Animal Models and in Patients."

TB-500 itself has far less research. A 2026 scoping review of the field found one study of TB-500 directly. That study measured how the body breaks TB-500 down and tested it on skin cells in a lab dish. It did not test healing in animals or people.

So when a site says TB-500 speeds skin healing, it is usually quoting thymosin beta-4 research. That research is promising, but it was done on the parent protein, not on TB-500.

How do BPC-157 and TB-500 compare for healing after surgery?

Are BPC-157 and TB-500 safe to use while you heal from surgery?

The early safety signs for BPC-157 look good. Besides the clean record in the three pilot studies, animal safety testing found BPC-157 well tolerated at high doses, with no toxic or lethal dose identified. Large human trials have not been done.

The FDA has flagged both peptides as compounding ingredients. It says compounded BPC-157 "may pose risk for immunogenicity for certain routes of administration and may have complexities with regard to peptide-related impurities," meaning a possible immune reaction and possible contaminants. It also says it lacks enough information to know whether BPC-157 would cause harm in people. For TB-500, the FDA notes risks of impurities and of the peptide clumping together, and says it "has not identified any human exposure data."

Both peptides work partly by growing new blood vessels, and lab research raises a question about tumor growth. For BPC-157, lab studies suggest it could feed the abnormal blood vessel growth tumors rely on. Other lab work points the other way and shows BPC-157 slowing uncontrolled cell growth and working against tumor formation. Researchers have also linked thymosin beta-4 to tumor spread in lab research, through blood vessel growth and cell movement. If you have any personal history of cancer, including breast cancer, tell your clinical team.

BPC-157 strongly raises nitric oxide. In theory, very high nitric oxide levels can change how your liver breaks down other drugs. This is a proposed effect, not one seen in people. Give your clinical team the full list of what you are taking after surgery, including pain medicine.

How do you try BPC-157 or TB-500 after a tummy tuck or breast reduction?

1. In the quiz, tell us which surgery you had, when you had it and how your incision is healing.
2. Have your surgeon's aftercare instructions and your full medication list ready for your clinical team.
3. Our clinical team reviews your history and can prescribe BPC-157 or TB-500 if it fits your recovery goal. They will tell you what to watch for while you heal.
4. For a sense of cost, one telehealth clinic, AnthologyRX, advertises a compounded BPC-157 and TB-500 plan at $199 billed monthly, or $537 every three months ($179 a month). That price includes clinical review, the medicine if prescribed, pharmacy fulfillment and shipping. Compounded medicines are made by a pharmacy to your prescription and are not FDA-approved products.

You want your incision to heal well and your scar to fade. Take the quiz so our clinical team can look at your surgery, your history and your goal, and see whether BPC-157 or TB-500 fits your recovery plan.